Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma

British Journal of Surgery

Volumn 99, Issue 9, 2012, Pages 1234-1240

  Bartsch, D K ^a   Waldmann, J ^a   Fendrich, V ^a   Boninsegna, L ^b,c   Lopez, C L ^a   Partelli, S ^b,c   Falconi, M ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF VERONA   (Italy)

^c SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DUODENUM TUMOR; EVALUATION; FEMALE; GASTRINOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREAS TUMOR; RETROSPECTIVE STUDY; ZOLLINGER ELLISON SYNDROME;

ADULT; AGED; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; GASTRINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; ZOLLINGER-ELLISON SYNDROME;

EID: 84864712042     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8843     Document Type: Article

References (23)

1. Ellison EH, Wilson SD,. The Zollinger-Ellison syndrome re-appraisal and evaluation of 260 registered cases. Ann Surg 1964; 160: 512-530.
2. Metz DC, Jensen RT,. Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome. In Endocrine Tumours of the Pancreas, Mignon M, Jensen RT, (eds). S. Karger: Basel, 1995; 240-257.
3. Hirschowitz BI, Mohmen J, Shaw S,. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome. Aliment Pharmacol Ther 1996; 10: 507-522. (Pubitemid 26254794)
4. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al., Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995; 108: 1637-1649.
5. Stabile BE, Passaro E Jr,. Benign and malignant gastrinoma. Am J Surg 1985; 149: 144-150. (Pubitemid 15156170)
6. Zogakis TG, Gibril F, Libutti SK, Norton JA, White DE, Jensen RT, et al., Management and outcome of patients with sporadic gastrinoma arising in the duodenum. Ann Surg 2003; 238: 42-48. (Pubitemid 38176406)
7. Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, et al., Surgery increases survival in patients with gastrinoma. Ann Surg 2006; 244: 410-419.
8. Kisker O, Bastian D, Bartsch DK, Nies C, Rothmund M,. Localization, malignant potential and surgical management of gastrinomas. World J Surg 1998; 22: 651-658. (Pubitemid 28277857)
9. Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, et al., An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 2006; 244: 845-851. (Pubitemid 44808610)
10. Yu F, Venzon D, Serrano J, Goebel SU, Doppman J, Gibril F, et al., Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999; 17: 615-630. (Pubitemid 29075250)
11. Norton JA, Jensen RT,. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004; 240: 757-773. (Pubitemid 39425767)
12. Norton JA, Fraker DL, Alexander R, Venzon DJ, Doppman JL, Serrano J, et al., Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 341: 635-644. (Pubitemid 29399042)
13. Jensen RT, Niederle B, Mitry E, Ramage JK, Steinmüller T, Lewington V, et al.,; European Neuroendocrine Tumor Society. Gastrinoma (duodenal and pancreatic). Neuroendocrinology 2006; 84: 173-182. (Pubitemid 46361051)
14. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, et al., Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance. Surgery 2000; 128: 958-966.
15. Langer P, Wild A, Hall A, Celik I, Rothmund M, Bartsch DK,. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal tumors. Br J Surg 2003; 90: 1599-1603. (Pubitemid 37533180)
16. Adler G, Seufferlein T, Brambs HJ, Feuerbach S, Grabenbauer G, Hahn S, et al., [S3-guidelines 'Exocrine pancreatic cancer' 2007.] Z Gastroenterol 2007; 45: 487-523. (Pubitemid 47056016)
17. Bosman F, Carneiro F, Hruban RH, Theise N,. WHO Classification of Tumours of the Digestive System. IARC Press: Lyons, 2010.
18. Ishikawa O, Ohigashi H, Sasaki Y, Kabuto T, Furukawa H, Nakamori S, et al., Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery 1997; 121: 244-249. (Pubitemid 27114444)
19. Thom AK, Norton JA, Axiotis CA, Jensen RT,. Location, incidence and malignant potential of duodenal gastrinomas. Surgery 1991; 110: 1086-1091.
20. Delcore R Jr, Cheung LY, Friesen SR,. Characteristics of duodenal wall gastrinomas. Am J Surg 1990; 160: 621-623.
21. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT, et al., Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994; 220: 320-328.
22. Chu QD, Hill HC, Douglass HO Jr, Driscoll D, Smith JL, Nava HR, et al., Predictive factors associated with long-term survival in patients with neuroendocrine tumours of the pancreas. Ann Surg Oncol 2002; 9: 855-862. (Pubitemid 35265635)
23. Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, et al., Pancreatic endocrine tumours: improved TNM staging and histopathological grading permit clinically efficient prognostic stratification of patients. Mod Pathol 2010; 23: 824-833.